Replies to post #28063 on CBA Florida Inc. (fka CBAI)

[Dew]

On Fidelity L2 Arca is sitting at .009 on the bid with a large number of shares. The bid support looks very strong right now.

[ThomCa-ching]

The Christopher Reeve Foundation just sent me some information on stem cell therapies that I have been reading. I found some information I didn't already know. Of course, the ISSCR (International society for Stem Cell Research) is supportive of emrbyonic and cord blood stem cell research, the Christopher Reeve foundation pointed me to something recent:

The 2007 Nobel Prize in Physiology or Medicine was awarded to Mario R. Capecchi, Martin J. Evans and Oliver Smithies for "principles for introducing specific gene modifications in mice by the use of embryonic stem cells"link

Although everyone, I am sure, on this board knows why cord blood is a valuable resource, the ISSCR answers this better for people just learning about CBAI:

Cord blood is rich in hematopoietic or blood stem cells and is currently being used as an experimental alternative to bone marrow transplantation. The collection process is completely non-invasive, the host-donor match required for transplantation is less stringent and cord blood has fewer mature immune cells and thus poses a lower risk of graft vs. host disease.

For more details on cord blood collection, storage and current therapies: www.nationalcordbloodprogram.org
link

Couple this with new legislation that might give credit of up to $1 billion to preventative treatments and its a good business start. The CEO has been public on being aggressive with the company "Our goal is simple: We want to be the dominant biological storage facility," -- Mr. Schissler insert-text-here and this April looks to be the month for CBAI.

From a chart standpoint, Cord Blood America looks pretty good. Almost an equal number of Sells as Buys. People are laying low and waiting for the news to come out.